Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review
Pediatric Blood & Cancer · 2026
DOI: 10.1002/pbc.32132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Ana Carolina Izurieta-Pacheco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Medulloblastoma, Cerebellar Neoplasms, Cancer Survivors, Quality of Life. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 196 Literaturangaben.
Abstract (Originalsprache)
Medulloblastoma (MB) treatment has advanced significantly with the integration of molecular subgrouping, enabling more precise risk stratification and tailored therapies. While survival outcomes have improved, long‐term treatment‐related morbidity remains a significant challenge. This review summarizes the spectrum of late effects experienced by survivors of pediatric MB. Special attention is placed on the impact of proton therapy in reducing treatment toxicity. As therapeutic paradigms continue to evolve, historical data may no longer accurately reflect the toxicity profile of contemporary treatments. Therefore, prospective, molecularly annotated survivorship studies are needed to determine whether recent advances in treatment will lead to sustained improvements in health, functionality, and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
- Oncology Department, Pediatric Cancer Center Barcelona, Hospital Sant Joan De Déu, Barcelona, Spain.
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
- Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
- Department of Pediatrics, Division of Endocrinology, The Hospital for Sick Children, Toronto, ON, Canada.
- Department of Psychology, The Hospital for Sick Children, Toronto, ON, Canada.
ORCID-Profile: Vijay Ramaswamy, Paul C Nathan, Julie Bennett
Zitieren
APA
Izurieta-Pacheco, A. C., Ramaswamy, V., Tsang, D. S., Rutka, J., Wasserman, J., Guger, S., Weidman, D. R., Nathan, P. C., Scheinemann, K., & Bennett, J. (2026). Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32132
Vancouver
Izurieta-Pacheco AC, Ramaswamy V, Tsang DS, Rutka J, Wasserman J, Guger S, et al. Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32132
BibTeX
@article{IzurietaPacheco2026,
author = {Izurieta-Pacheco, Ana Carolina and Ramaswamy, Vijay and Tsang, Derek S and Rutka, James and Wasserman, Jonathan and Guger, Sharon and Weidman, Danielle R and Nathan, Paul C and Scheinemann, Katrin and Bennett, Julie},
title = {Late Effects in Survivors of Pediatric Medulloblastoma: A Comprehensive Review},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/pbc.32132}
}
EUVIMED